ExpreS2ion Biotech Holding AB (publ) Overview
Latest P/E ratio for ExpreS2ion Biotech Holding AB (publ): -0.16 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-0.16
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for EXPRS2.ST is -0.16. That is below the Healthcare sector average of 66.31. Investors often review this figure alongside ExpreS2ion Biotech Holding AB (publ)'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, EXPRS2.ST currently prints -0.16 for P/E ratio, while the sector average sits near 66.31. That is roughly 100.2% below the sector mean. Large gaps often invite a closer look at ExpreS2ion Biotech Holding AB (publ)'s growth, margins, and balance sheet.
A P/E ratio of -0.16 for ExpreS2ion Biotech Holding AB (publ) is not 'good' or 'bad' on its own. Compare it with the peer average (66.31) and with EXPRS2.ST's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting EXPRS2.ST's P/E ratio (-0.16), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack ExpreS2ion Biotech Holding AB (publ)'s P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
